Medical Management of Heavy Vaginal Bleeding in a 40-Year-Old Woman
Start with monophasic combined oral contraceptives containing 30-35 μg ethinyl estradiol with levonorgestrel or norgestimate as first-line treatment after ruling out pregnancy, infection, and structural pathology. 1
Initial Evaluation Before Treatment
Before initiating any medication, you must exclude:
- Pregnancy (obtain hCG test) 2
- Sexually transmitted infections (particularly gonorrhea and chlamydia in reproductive-aged women) 1
- Structural lesions (perform pelvic examination and transvaginal ultrasound to identify fibroids, polyps, or other pathology) 1, 2
- Cervical pathology (speculum examination and Pap smear per guidelines) 2
First-Line Medical Treatment
Combined oral contraceptives (COCs) are the recommended initial therapy:
- Use a monophasic formulation with 30-35 μg ethinyl estradiol combined with levonorgestrel or norgestimate 1, 3
- COCs reduce menstrual blood loss by inducing regular shedding of a thinner endometrium 1
- Additional benefits include decreased cramping, improvement in acne, and reduced risk of endometrial and ovarian cancers 1, 3
Before prescribing COCs, assess thrombotic risk factors:
- COCs increase venous thromboembolism risk 3-4 fold 1, 3
- Monitor blood pressure at follow-up visits 1, 3
Management of Persistent Bleeding on COCs
If bleeding continues despite COC therapy:
- Add NSAIDs for 5-7 days during bleeding episodes as first-line adjunctive therapy 1, 4
- NSAIDs (such as mefenamic acid, indomethacin, or diclofenac) reduce menstrual blood loss acutely 5, 6
- For extended/continuous COC regimens, consider a hormone-free interval of 3-4 consecutive days for heavy bleeding, but not during the first 21 days of use and not more than once per month 1
Re-evaluate for underlying pathology if bleeding persists beyond 3-6 months:
- Check for IUD displacement (if applicable), STDs, pregnancy, or new pathologic uterine conditions such as polyps or fibroids 1, 4
Alternative First-Line Options
Levonorgestrel intrauterine system (LNG-IUD):
- Results in 71-95% reduction in menstrual blood loss, comparable to endometrial ablation 3
- Most effective medical treatment for heavy menstrual bleeding 2, 7
- Particularly useful if contraception is also desired 6, 8
Tranexamic acid:
- Reduces menstrual blood loss by 20-60% 8, 9
- Appropriate when hormonal treatment is contraindicated or immediate pregnancy is desired 2
- FDA warning: Contraindicated in women with active thromboembolic disease or history/risk of thrombosis 5
Second-Line Options
If first-line treatments fail or are contraindicated:
- Depot medroxyprogesterone acetate (DMPA) 150 mg intramuscularly every 12 weeks 3
- For heavy bleeding with DMPA, add NSAIDs for 5-7 days 3
- Note: Cyclic oral progestogens reduce menstrual blood loss by approximately 87% but are less effective than other options 3, 7
Counseling and Follow-Up
Provide anticipatory guidance:
- Unscheduled spotting or bleeding is common during the first 3-6 months of hormonal therapy and generally not harmful 5, 1
- Enhanced counseling about expected bleeding patterns reduces discontinuation rates 5
Follow-up approach:
- No routine follow-up visit is required 1, 3
- Patients should return for side effects or concerns 1, 4
- Assess satisfaction with the method and any health status changes at follow-up 1, 4
When to Consider Surgical Options
If medical therapies fail and the patient does not desire future pregnancy: